20 results
8-K
EX-99.1
FHTX
Foghorn Therapeutics Inc
16 Apr 24
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
7:01am
of capital markets expertise, established relationships within the financial community, and a deep understanding of the industry landscape," said Adrian
10-K
2020 FY
FHTX
Foghorn Therapeutics Inc
18 Mar 21
Annual report
4:02pm
components work in concert in both healthy and diseased cells. While chromatin remodeling complexes have been known in the scientific community … in the United States to sell our products. We believe that such an organization will be able to address the community of oncologists who are the key specialists
424B4
86zwuk1 hkw
26 Oct 20
Prospectus supplement with pricing info
4:14pm
424B4
r1kvjf6o6exw7us hidi
23 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.18
xo73qmr q901kt5kv
19 Oct 20
IPO registration (amended)
6:06am
S-1/A
auw3m5rh15t igtvg2m
19 Oct 20
IPO registration (amended)
6:06am
S-1
EX-10.9
u3ro5au 26bv1u
2 Oct 20
IPO registration
4:03pm
S-1
oan9q6lhue
2 Oct 20
IPO registration
4:03pm
S-1
EX-10.1
g4y yxzbq
2 Oct 20
IPO registration
4:03pm
S-1
EX-10.5
rwn g47csglhe
2 Oct 20
IPO registration
4:03pm
S-1
EX-10.6
3jqkrdu 95ox4
2 Oct 20
IPO registration
4:03pm
DRS
EX-10.1
9ct28bd1vx
28 Aug 20
Draft registration statement
12:00am
DRS
EX-10.9
hxzj9wps93iltn
28 Aug 20
Draft registration statement
12:00am
DRS
EX-10.5
ht3ecfuia5sfiq
28 Aug 20
Draft registration statement
12:00am
DRS
EX-10.6
za0zdh 69
28 Aug 20
Draft registration statement
12:00am
DRS
j8oe lkle
28 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next